StonvexLoading…
StonvexStonvexStonvexCore line items from EML's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-03 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $248.97M | $272.75M | $258.86M | $279.27M |
Operating Income | $10.67M | $20.15M | $17.03M | $14.17M |
Net Income | $7.13M | $-8.53M | $8.59M | $12.30M |
EPS (Diluted) | $1.17 | $-1.37 | $1.37 | $1.97 |
Total Assets | $216.68M | $235.31M | $252.04M | $261.52M |
Total Liabilities | $92.03M | $114.62M | $119.56M | $134.91M |
Cash & Equivalents | $7.41M | $14.01M | $8.05M | $10.19M |
Free Cash Flow OCF − CapEx | $4.90M | $9.68M | $20.00M | $4.09M |
Shares Outstanding | 6.04M | 6.16M | 6.22M | 6.22M |